Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Bayer Nears Buy of Roche Unit
July 5, 2004
| A version of this story appeared in
Volume 82, Issue 27
According to company insiders, Bayer is now in exclusive negotiations to acquire Roche's consumer health care unit. Some five other contenders, including several investment firms, have dropped out, they say. At the company's Innovation Day press forum last week, Bayer Chairman Werner Wenning refused to comment on the latest report, which predicts that Bayer will pay nearly $2 billion for the Roche unit. The Bayer staffers are optimistic that the deal will succeed and see a good fit between the Roche business and Bayer's own consumer health care products division.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X